EATG joined its voice with EPHA and other organisations to call on the European Commission to include their considerations in the revision of the general pharmaceutical legislation.
Enhancing patients’ access to high-quality and affordable medicinal products across the European Union while preserving the financial sustainability of healthcare systems should be the overarching aim of the current revision of the general pharmaceutical legislation. Civil society organisations representing healthcare providers, patients, healthcare professionals and payers have joined forces to outline how the revision of the general pharmaceutical legislation should:
- Foster affordability to improve access to high-quality medicinal products,
- Improve the assessment and evidence requirement of medicinal products’ effectiveness and safety, and
- Ensure a sufficient supply of medicinal products and combat shortages.
We call on the European Commission to include the considerations that have been put forward in this joint statement in the revision of the general pharmaceutical legislation.
Download the Statement
Source : EPHA
Related Endorsements and Sign-ons
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.